Gnca stock price forecast
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. What Is Genocea Biosciences Inc’s (GNCA) Share Price Doing ... Oct 10, 2017 · Genocea Biosciences Inc (NASDAQ:GNCA), a biotechnology company based in United States, received a lot of attention from a substantial price increase on the NasdaqGM in the over the last few months.With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. GNCA - Genocea Biosciences Inc Share Price Profile Summary. Genocea Biosciences, Inc. is a biopharmaceutical company developing personalized cancer immunotherapies. The Company’s Antigen Lead Acquisition System (ATLAS) technology platform allows to identify targets based on each person’s tumor antigen-specific T cell responses. Genocea Biosciences (GNCA) Prices $55M Concurrent Public ... Genocea Biosciences (GNCA) Prices $55M Concurrent Public Offerings 53,365,000 shares of its common stock and accompanying Class A warrants to purchase up …
GNCA -- Is Its Stock Price A Worthy Investment? Learn More.
GNCA: Genocea Biosciences, Inc. - Price & Consenus Chart ... GNCA: Genocea Biosciences, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Genocea Biosciences, Inc. from Zacks Investment Research company's stock price along Genocea prices stock offering - Genocea Biosciences, Inc ... Genocea Biosciences (NASDAQ:GNCA) has priced its public offering of 10.5M common shares at $3.50/share, for gross proceeds of $36.75M. Underwriters over-allotment is … Genocea Biosciences (NasdaqCM:GNCA) - Share price, News ... Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, to profile patient’s CD4+ and CD8+ T cell immune responses to potential target or antigen in that patient's tumor.
GNCA: Genocea Biosciences, Inc. - Price & Consenus Chart ...
In depth view into GNCA (Genocea Biosciences) stock including the latest price, news, dividend history, earnings information and financials. 27 Sep 2019 we're taking a close look at Genocea (GNCA) to show why the stock the company over the last six months with an average price target of
Get breaking news and analysis on Genocea Biosciences, Inc. (GNCA) stock, price quote and chart, trading and investing tools.
GNCA | Genocea Biosciences Inc. Company Profile ... Company profile for Genocea Biosciences Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed GNCA description & address. General Communication - GNCMA - Stock Price & News | The ...
Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 15.00, with a high estimate of 32.00
GNCA Genocea Biosciences — Stock Price and Discussion ... Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Genocea Biosciences, Inc. Common Stock (GNCA) Earnings ... Find the latest Earnings Report Date for Genocea Biosciences, Inc. Common Stock (GNCA) at Nasdaq.com. Genocea Biosciences Stock Forecast: up to 1.769 USD ...
GNCA | Genocea Biosciences Inc. Company Profile ... Company profile for Genocea Biosciences Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed GNCA description & address. General Communication - GNCMA - Stock Price & News | The ... Mar 25, 2020 · Real time General Communication (GNCMA) stock price quote, stock graph, news & analysis. Real time General Communication (GNCMA) stock price quote, stock graph, news & analysis. GNCA (Genocea Biosciences Inc) Forecast & Analyst Opinion ... Get free Genocea Biosciences Inc (GNCA) daily & weekly technical and fundamental forecasts, analyses and news written by FX Empire's professional analysts. Enter Now!